Suppliers / Guang'An Kingday Pharma And Chem

Guang'An Kingday Pharma And Chem

China Updated 9 July 2026

Guang'An Kingday Pharma And Chem is an API manufacturer based in China. It holds 5 active US drug master files across a filed portfolio of 5 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 24 May 2024 as VAI.

5
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 24 May 2024 VAI US FDA
  • 4 March 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3009846816

What they file, and where

Molecule Regulators Docs
Aztreonam US FDA 1
Dexmedetomidine US FDA 1
Diazoxide US FDA 1
Fosphenytoin US FDA 1
Lifitegrast US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Guang'An Kingday Pharma And Chem

Does Guang'An Kingday Pharma And Chem hold a US DMF or a CEP?
Guang'An Kingday Pharma And Chem holds 5 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Guang'An Kingday Pharma And Chem FDA-registered?
One site operated by Guang'An Kingday Pharma And Chem carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Guang'An Kingday Pharma And Chem's last inspection go?
The most recent inspection on record closed on 24 May 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Guang'An Kingday Pharma And Chem manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Guang'An Kingday Pharma And Chem make?
5 molecules are on record against Guang'An Kingday Pharma And Chem, including Aztreonam, Dexmedetomidine, Diazoxide and Fosphenytoin. Each links through to that molecule's full manufacturer list.
Which regulators recognise Guang'An Kingday Pharma And Chem's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Guang'An Kingday Pharma And Chem comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 24 May 2024.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates